RecruitingNCT05607888

Prospective Study of Sinonasal and Skull-base Tumours Management

Prospective Observational Study of Sinonasal and Skull-base Tumours Management in a Tertiary Referral Otorhinolaryngology Service


Sponsor

University Medical Centre Ljubljana

Enrollment

120 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are: * what is the caseload of patients with the included pathology in our centre * what are the results of management of these cases * what are the epidemiological characteristics of included patients * what is the quality of life of included patients.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study collects data to better understand how doctors manage cancers in the sinuses, nose, and skull base — a complex region of the head. It aims to improve treatment approaches by tracking outcomes over time. **You may be eligible if...** - You have a cancer affecting the sinuses, nasal cavity, or skull base - Your cancer has grown into or through the skull base area - You can provide written informed consent **You may NOT be eligible if...** - Your skull-base cancer started in the temporal bone (ear region) and does not involve the central skull base Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Medical Centre Ljubljana

Ljubljana, Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05607888


Related Trials